Evolving Landscape for Managing Cardiovascular, Renal and Metabolic Conditions

Boehringer Ingelheim executives Brian Hilberdink and Neerja Balachander discuss key developments in managing cardiovascular, renal, and metabolic conditions. The focus is on the evolving landscape of these medical areas.